• Investment Report Reveals Medical Cures not Profitable for Big Pharma - Sick People Needed to Sustain Drug Sales

    A report that made its way through the corporate sponsored "mainstream" media last week demonstrated what those of us in the alternative health media have been publishing for years: Pharmaceutical products which actually cure people are not invested in, simply because it is not a sustainable market when people are cured and no longer need Big Pharma's drugs. Investors cannot afford to invest in such products. Originally reported on CNBC.com, an April 10 report by Goldman Sachs analysts entitled "The Genome Revolution" addressed the question: "Is curing patients a sustainable business model?"

    Read full story...